Background: Limited brain metastasis is treated definitively with stereotactic radiosurgery when surgical resection is not indicated. Although this has historically been performed in a single fraction, multi-fraction approaches such as fraction radiosurgery (FSRS) and staged radiosurgery (SSRS) have been recently examined as alternative approaches for larger lesions to permit better tumor control without increased toxicity. Case Report: We present the case of a patient who developed symptomatic radionecrosis in two brain metastasis, 2.3 cm and 2.1 cm in size, which were treated with 18 Gy in one fraction, but no radionecrosis in a 3.3 cm lesion treated in two fractions of 15 Gy nor in two punctate lesions that were treated in one fraction of 20 Gy. Although she did not respond to steroids, she responded to bevacizumab symptomatically and on neuroimaging. Conclusion: Congruent with other recent studies, our report suggests that large brain metastasis should be considered for FSRS/SSRS.

Original languageEnglish (US)
Pages (from-to)1445-1449
Number of pages5
JournalAnticancer Research
Issue number3
StatePublished - Mar 2021


  • Fractionated stereotactic radiosurgery
  • Large brain metastasis
  • Radiographical radionecrosis
  • Staged stereotactic radiosurgery
  • Symptomatic radionecrosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Staged stereotactic radiosurgery decreases symptomatic radionecrosis in large brain metastasis'. Together they form a unique fingerprint.

Cite this